Minaris Advanced Devices

Executive Summary

Minaris Advanced Devices is a specialized Contract Development and Manufacturing Organization (CDMO) focused exclusively on cell and gene therapies, offering end-to-end services from early development to commercial supply. Founded in 2019 and headquartered in San Diego, the company leverages over 40 years of testing expertise and a proven track record of more than 7,500 GMP batches. Its integrated platform addresses the critical manufacturing bottleneck in advanced therapies, positioning it as a key partner for biotech and pharmaceutical firms. As the cell and gene therapy market expands, Minaris stands to benefit from increased outsourcing demand due to its regulatory experience and scalable capabilities.

Upcoming Catalysts (preview)

• Q3 2026Announcement of new commercial-scale manufacturing facility70% success
• Q4 2026Securing a long-term supply agreement with a top-20 pharma company50% success
• Q2 2026Completion of FDA pre-license inspection for a key client therapy80% success